A Must-Read Assessment of 340B Legislation Encourages Policymakers to Think Hard About ‘Tradeoffs’
Shares:
There were three big takeaways from yesterday’s White House “listening session” on PBMs: The White House wants the David vs Goliath narrative. Of the five non-government speakers, four represented pharmacies.
Programming note: No Curve tomorrow. Back Monday. Behave, y’all. We’re in the thick of earnings season, and we had quarterly numbers drop today from Sanofi, AstraZeneca, AbbVie, and Roche. All
Premium Content This content is reserved for premium subscribers of Premium Membership. To Access this and other great posts, consider upgrading to premium. UpgradeLink ConjuctionSign In Powered by beehiiv